Melanoma maligno

TERAPIA ADYUVANTE

Interferón alfa adyuvante para melanoma de alto riesgo - ECOG 1684
Este el posiblemente el artículo más viejo que continúa vigente.

- Kirkwood JM, Strawarderman MH, Ernstoff MS, et al. Interferon alfa 2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7.


Peginterferon adyuvante - EORTC 18991

- Eggermont AMM, Suciu S, Santinami M, et al. for the EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. The Lancet 2008; 372:117-126